/C O R R E C T I O N -- Bayer Pharmaceuticals Corporation/ In the news release, FDA Approves Avelox(R) (moxifloxacin HCI) for Community Acquired Pneumonia Due to Multi-Drug Resistant Streptococcus pneumoniae, issued earlier today by Bayer Pharmaceuticals Corporation over PR Newswire, we are advised by a representative of the company that the third paragraph, last sentence, should read "... rates of 93% to 100%" rather than "... rates of 93% to 95%" as originally issued inadvertently. PRNewswire -- May 19 DATASOURCE: Bayer Pharmaceuticals Corporation

Copyright